Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.40 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.35 |
| ▸ | FNTA | P49354 | 1/20 | 0.34 |
| ▸ | FNTB | P49356 | 1/20 | 0.34 |
| ▸ | TERT | O14746 | 3/20 | 0.32 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.32 |
| ▸ | BLM | P54132 | 2/20 | 0.32 |
| ▸ | FABP4 | P15090 | 2/20 | 0.32 |
| ▸ | F7 | P08709 | 2/20 | 0.32 |
| ▸ | F3 | P13726 | 2/20 | 0.32 |
| ▸ | PPARG | P37231 | 2/20 | 0.32 |
| ▸ | PPARD | Q03181 | 2/20 | 0.32 |
| ▸ | PPARA | Q07869 | 2/20 | 0.32 |
| ▸ | GMNN | O75496 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2046603 | 1.00 | MAPT (0.40) | MAPTABCC4HIF1ATBXAS1TSHR | |
| SCHEMBL4953960 | 0.98 | MAPT (0.43) | MAPTABCC4HIF1ATBXAS1TSHR | |
| SCHEMBL10337658 | 0.98 | MAPT (0.43) | MAPTABCC4HIF1ATBXAS1TSHR | |
| SCHEMBL16661276 | 0.98 | MAPT (0.43) | MAPTABCC4HIF1ATBXAS1TSHR | |
| SCHEMBL2048074 | 0.93 | HIF1A (0.41) | MAPTABCC4HIF1ATBXAS1TSHR | |
| SCHEMBL1824152 | 0.93 | HIF1A (0.41) | MAPTABCC4HIF1ATBXAS1TSHR | |
| SCHEMBL1821741 | 0.83 | — | — | |
| SCHEMBL2025802 | 0.83 | TBXAS1 (0.47) | TBXAS1TSHRHSD17B10ALOX15FNTA | |
| SCHEMBL740074 | 0.82 | MAPT (0.61) | MAPTABCC4TBXAS1TSHRHSD17B10 | |
| SCHEMBL1843581 | 0.80 | MAPT (0.65) | MAPTABCC4TBXAS1TSHRHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2324069-B1 | MONOMER MIXTURE, POLYMER, COATING MEANS AND METHOD FOR PRODUCING A COATING | EVONIK ROEHM GMBH (DE) | 2013-12-18 | — | — | EP | claimed |
| US-20110144267-A1 | FUNCTIONALIZED (METH)ACRYLATE MONOMER, POLYMER, COATING AGENT, AND PRODUCTION AND CROSS-LINKING METHOD | EVONIK ROEHM GMBH (DE) | 2011-06-16 | — | — | US | claimed |
| EP-2324069-A1 | MONOMER MIXTURE, POLYMER, COATING MEANS AND METHOD FOR PRODUCING A COATING | Evonik Röhm GmbH (DE) | 2011-05-25 | — | — | EP | claimed |
| WO-2010026118-A1 | MONOMER MIXTURE, POLYMER, COATING MEANS AND METHOD FOR PRODUCING A COATING | EVONIK RÖHM GMBH (DE) | 2010-03-11 | — | — | WO | claimed |
| EP-2016153-A1 | CONTACT ADHESIVE CONTAINING n-BUTYLACRYLATE AND HYDROXYBUTYL(METH)ACRYLATE. | BASF SE (DE) | 2009-01-21 | — | — | EP | claimed |
| EP-2016152-A1 | CONTACT ADHESIVE CONTAINING 2-ETHYLHEXYLACRYLATE AND HYDROXYBUTYL(METH)ACRYLATE | BASF SE (DE) | 2009-01-21 | — | — | EP | claimed |
| WO-2007125031-A1 | CONTACT ADHESIVE CONTAINING n-BUTYLACRYLATE AND HYDROXYBUTYL(METH)ACRYLATE. | BASF SE (DE) | 2007-11-08 | — | — | WO | claimed |
| WO-2007125040-A1 | CONTACT ADHESIVE CONTAINING 2-ETHYLHEXYLACRYLATE AND HYDROXYBUTYL(METH)ACRYLATE | BASF SE (DE) | 2007-11-08 | — | — | WO | claimed |
| EP-3313826-A1 | SUBSTITUTED TRIAZINES AND A METHOD FOR PRODUCING SAME | Covestro Deutschland AG (DE) | 2018-05-02 | — | — | EP | disclosed |
| EP-3313827-A1 | SUBSTITUTED TRIAZINES | Covestro Deutschland AG (DE) | 2018-05-02 | — | — | EP | disclosed |
| EP-3233791-A1 | MOISTURE-STABLE HOLOGRAPHIC MEDIA | Covestro Deutschland AG (DE) | 2017-10-25 | — | — | EP | disclosed |
| EP-3207178-A1 | SOLIDIFYING COMPOSITION FOR PAPER AND CARDBOARD | BASF SE (DE) | 2017-08-23 | — | — | EP | disclosed |
| WO-2016207158-A1 | SUBSTITUTED TRIAZINES AND A METHOD FOR PRODUCING SAME | COVESTRO DEUTSCHLAND AG (DE) | 2016-12-29 | — | — | WO | disclosed |
| WO-2016207157-A1 | SUBSTITUTED TRIAZINES | COVESTRO DEUTSCHLAND AG (DE) | 2016-12-29 | — | — | WO | disclosed |
| EP-2324069-B1 | MONOMER MIXTURE, POLYMER, COATING MEANS AND METHOD FOR PRODUCING A COATING | EVONIK ROEHM GMBH (DE) | 2013-12-18 | — | — | EP | disclosed |
| WO-2013010813-A1 | PROCESS FOR THE PREPARATION OF RADIATION CURABLE COMPOSITIONS | CYTEC SURFACE SPECIALTIES, S.A. (BE) | 2013-01-24 | — | — | WO | disclosed |
| EP-2324069-A1 | MONOMER MIXTURE, POLYMER, COATING MEANS AND METHOD FOR PRODUCING A COATING | Evonik Röhm GmbH (DE) | 2011-05-25 | — | — | EP | disclosed |
| EP-2321254-A1 | FUNCTIONALIZED (METH)ACRYLATE MONOMER, POLYMER, COATING AGENT, AND PRODUCTION AND CROSS-LINKING METHOD | Evonik Röhm GmbH (DE) | 2011-05-18 | — | — | EP | disclosed |
| WO-2010026204-A1 | FUNCTIONALIZED (METH)ACRYLATE MONOMER, POLYMER, COATING AGENT, AND PRODUCTION AND CROSS-LINKING METHOD | EVONIK RÖHM GMBH (DE) | 2010-03-11 | — | — | WO | disclosed |
| WO-2010026118-A1 | MONOMER MIXTURE, POLYMER, COATING MEANS AND METHOD FOR PRODUCING A COATING | EVONIK RÖHM GMBH (DE) | 2010-03-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110144267-A1 | FUNCTIONALIZED (METH)ACRYLATE MONOMER, POLYMER, COATING AGENT, AND PRODUCTION AND CROSS-LINKING METHOD | DNMT1, TET1, MGMT | MAPT 2189/4885ABCC4 4240/4885HIF1A 161/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.